USPTO serial 75442068
TWINJECTJR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOOD, CAROLINE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TWINJECTJR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Elkhart, IN
HOLLISTER-STIER LABORATORIES, LLC.
SPOKANE, WA
Other trademarks owned by HOLLISTER-STIER LABORATORIES, LLC.
Elkhart, IN
FLEET CAPITAL CORPORATION, AS AGENT
GLASTONBURY, CT
Other trademarks owned by FLEET CAPITAL CORPORATION, AS AGENT
SAN DIEGO, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | auto-injectors containing epinephrine for the treatment of anaphylactic reactions and severe life-threatening asthma attacks | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BAYER CORPORATION
- Other trademarks owned by HOLLISTER-STIER LABORATORIES, LLC.
- Other trademarks owned by BAYER CORPORATION
- Other trademarks owned by FLEET CAPITAL CORPORATION, AS AGENT
- Other trademarks owned by VERUS PHARMACEUTICALS, INC.
- Other trademarks in Class 005
- Similar marks named TWINJECTJR
- Prosecution event ARAA explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 22, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 15, 2002 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 10, 2002 | PAPER RECEIVED | — | |
| Nov 16, 2001 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 7, 2001 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 4, 2001 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 25, 2001 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 29, 2001 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 1, 2000 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 5, 2000 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 12, 2000 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 14, 1999 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 10, 1999 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 1, 1999 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 9, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 5, 1999 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 12, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 12, 1998 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 22, 1998 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Oct 16, 1998 | DOCK | ASSIGNED TO EXAMINER | — |